These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 3085698)

  • 21. Influence of the method of application on pharmacokinetics of nitroglycerin from ointment in humans.
    Sved S; McLean WM; McGilveray IJ
    J Pharm Sci; 1981 Dec; 70(12):1368-9. PubMed ID: 6798193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transdermal nitroglycerin ointment and patches.
    Todd B
    Geriatr Nurs; 1986; 7(3):152-4. PubMed ID: 3084347
    [No Abstract]   [Full Text] [Related]  

  • 23. [The effect of various cutaneously administered nitroglycerin preparations on coronary heart disease].
    Zeiher A; Drexler H; Bonzel T; Wollschläger H; Hust MH; Löllgen H; Just H
    Schweiz Med Wochenschr Suppl; 1984; 16():70-6. PubMed ID: 6429852
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experience with nitrobid (2% nitroglycerine) ointment as an aid to venepuncture.
    Parakh SC; Patwari A
    Br J Anaesth; 1986 Jul; 58(7):822. PubMed ID: 3089243
    [No Abstract]   [Full Text] [Related]  

  • 25. Relative bioavailability of a new transdermal nitroglycerin delivery system.
    Noonan PK; Gonzalez MA; Ruggirello D; Tomlinson J; Babcock-Atkinson E; Ray M; Golub A; Cohen A
    J Pharm Sci; 1986 Jul; 75(7):688-91. PubMed ID: 3093667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retrospective post-marketing surveillance of Transiderm-Nitro 5 in general practice in the United Kingdom.
    Tattersall AB; Bridgman KM; Carr M
    J Int Med Res; 1985; 13(4):222-8. PubMed ID: 3930310
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rethinking the Role of Nitroglycerin Ointment in Ischemic Vascular Filler Complications: An Animal Model With ICG Imaging.
    Hwang CJ; Morgan PV; Pimentel A; Sayre JW; Goldberg RA; Duckwiler G
    Ophthalmic Plast Reconstr Surg; 2016; 32(2):118-22. PubMed ID: 25794030
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nitroglycerin levels after administration via transdermal therapeutic system or nitroglycerin ointment.
    Curry SH; Kwon HR; Perrin JH; Culp JR; Pepine CJ; Yu W
    Lancet; 1984 Jun; 1(8389):1297. PubMed ID: 6145002
    [No Abstract]   [Full Text] [Related]  

  • 29. Transdermal glyceryl trinitrate patches (Transiderm-Nitro).
    Drug Ther Bull; 1986 Jan; 24(2):5-6. PubMed ID: 3086066
    [No Abstract]   [Full Text] [Related]  

  • 30. 0.4% nitroglycerin ointment : in the treatment of chronic anal fissure pain.
    Fenton C; Wellington K; Easthope SE
    Drugs; 2006; 66(3):343-9. PubMed ID: 16526822
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma concentration of cutaneously applied trinitroglycerin.
    Magometschnigg D; Horwatitsch H; Pichler M
    Int J Clin Pharmacol Ther Toxicol; 1983 Apr; 21(4):178-82. PubMed ID: 6408014
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nitroglycerin levels after administration via transdermal therapeutic system or nitroglycerin ointment.
    Taylor SH
    Lancet; 1984 Jul; 2(8394):97. PubMed ID: 6146027
    [No Abstract]   [Full Text] [Related]  

  • 33. Acceptance of transcutaneous nitroglycerin patches by patients with angina pectoris.
    Schrader BJ; Bauman JL; Zeller FP; Shanes JG; Rich S
    Pharmacotherapy; 1986; 6(2):83-6. PubMed ID: 3086849
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative pharmacokinetics and bioavailability of nitroglycerin and its metabolites from Transderm-Nitro, Nitrodisc, and Nitro-Dur II systems using a stable-isotope technique.
    Sun JX; Piraino AJ; Morgan JM; Joshi JC; Cipriano A; Chan K; Redalieu E
    J Clin Pharmacol; 1995 Apr; 35(4):390-7. PubMed ID: 7650229
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Serum concentration of glyceryl trinitrate (GTN) in transdermal application of GTN dressings of various origins].
    Heidemann R; Menke G; Letzel H; Rietbrock N
    Dtsch Med Wochenschr; 1985 Oct; 110(41):1568-72. PubMed ID: 3930197
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of atenolol and nitroglycerin ointment on exertion tolerance in coronary disease].
    Koenig W; Diehm C
    Dtsch Med Wochenschr; 1983 Nov; 108(47):1798-803. PubMed ID: 6416805
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhancement of skin-flap survival using nitroglycerin ointment.
    Rohrich RJ; Cherry GW; Spira M
    Plast Reconstr Surg; 1984 Jun; 73(6):943-8. PubMed ID: 6427801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transdermal nitroglycerin systems: methods for comparison.
    Harrison LI; Riedel DJ
    Clin Ther; 1991; 13(3):361-7. PubMed ID: 1954637
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Bioavailability of glycerol trinitrate (nitroglycerin) from an ointment preparation].
    Gielsdorf W; Schlegel E; Settlage JA; Jaeger H; Fink E
    Arzneimittelforschung; 1983; 33(12):1677-9. PubMed ID: 6421295
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nitroglycerin ointment: a review.
    Francis GS; Hagan AD
    Angiology; 1977 Dec; 28(12):873-8. PubMed ID: 414640
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.